Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Prior to ePA, clinicians reported spending hours weekly managing PA tasks
Phase 2 Trial Results The pivotal Phase 2 clinical trial results for retatrutide were published in The New England Journal of Medicine in June 2023 and generated significant attention from the medical community and general public (Jastreboff et al., 2023)
Carmina, E., & Longo, R
Curr Cardiovasc Risk Rep 17 , 155165 (2023)
While further studies are underway to assess their efficacy for opioid, cocaine, and stimulant use disorders, current findings suggest that GLP-1 RAs may offer new avenues for addressing maladaptive reward-driven behaviors beyond obesity
C2 is 20-fold more selective at human FFAR2 than at human FFAR3, while it is equipotent at both mouse orthologs
US$ 24.67
US$ 28.10
US$ 21.52
US$ 25.30
US$ 27.73
US$ 27.72
